$1.44
-0.02-1.03%
At close: -
$1.56
0.128.33%
After Hours: Dec 18, 8:42 AM EDT
Comments
Loading...
XTL Biopharmaceuticals (XTLB) Forecast
NewsEarningsXTL Biopharmaceuticals (XTLB) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestXTL Biopharmaceuticals (NASDAQ:XTLB) Stock Quotes, Forecast and News Summary
XTL Biopharmaceuticals Stock (NASDAQ: XTLB) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy XTL Biopharmaceuticals (XTLB) stock?
You can purchase shares of XTL Biopharmaceuticals (NASDAQ:XTLB) through any online brokerage.
Who are XTL Biopharmaceuticals (XTLB) competitors?
Other companies in XTL Biopharmaceuticals’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Vincerx Pharma (NASDAQ:VINC), Alzamend Neuro (NASDAQ:ALZN), Galecto (NASDAQ:GLTO) and Cellectar Biosciences (NASDAQ:CLRB).
What is the forecast, or price target, for XTL Biopharmaceuticals (XTLB) stock?
There is no analysis for XTL Biopharmaceuticals to provide a consensus price target.
What is the current price for XTL Biopharmaceuticals (XTLB)?
The stock price for XTL Biopharmaceuticals (NASDAQ: XTLB) is $1.44 last updated December 20, 2024 at 1:53 PM EST.
Does XTL Biopharmaceuticals (XTLB) pay a dividend?
There are no upcoming dividends for XTL Biopharmaceuticals.
When is XTL Biopharmaceuticals (NASDAQ:XTLB) reporting earnings?
XTL Biopharmaceuticals’s Q4 earnings are confirmed for Thursday, February 20, 2025.
Is XTL Biopharmaceuticals (XTLB) going to split?
There is no upcoming split for XTL Biopharmaceuticals.
What sector and industry does XTL Biopharmaceuticals (XTLB) operate in?
XTL Biopharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.